What WHO pregnancy classification applies to a woman with a prior episode of peripartum cardiomyopathy, and what is the risk of recurrence in a subsequent pregnancy?

WHO Classification and Recurrence Risk for Prior Peripartum Cardiomyopathy

A pregnant patient with a history of peripartum cardiomyopathy (PPCM) is classified as WHO Class III if left ventricular function has normalized (LVEF ≥50%), or WHO Class IV if left ventricular dysfunction persists (LVEF <50%), with a recurrence risk of approximately 30-50% regardless of recovery status.

WHO Risk Classification

The WHO maternal cardiovascular risk classification for women with prior PPCM depends critically on current left ventricular function:

• WHO Class III (High Risk): Women with recovered LVEF (≥50%) before pregnancy. These patients face significantly increased risk but pregnancy is not absolutely contraindicated with intensive monitoring.

• WHO Class IV (Very High Risk/Pregnancy Contraindicated): Women with persistent LV dysfunction (LVEF <50%), particularly those with LVEF <25% or non-normalized function. Pregnancy should be strongly discouraged in this group 1, 2.

The distinction is crucial because maternal mortality differs dramatically between these groups: 1.7% in recovered patients versus 10.9% in non-recovered patients 3.

Recurrence Risk in Subsequent Pregnancy

Overall Risk Profile

The recurrence risk of PPCM is 30-50% across all patients with prior PPCM 1. Recent meta-analysis data from 2026 confirms a 32% relapse rate in first subsequent pregnancies 4, with another systematic review showing 33% recurrence 3.

Risk Stratification by Cardiac Function

Critical finding: Recurrence occurs in both recovered and non-recovered groups, though outcomes differ substantially:

• Recovered LVEF (≥50%):

  • Relapse rate: 21-24% 2, 3, 4
  • Maternal mortality: 0% in the Elkayam study 2
  • Most relapses are transient with minor decreases in LVEF 5

• Non-recovered LVEF (<50%):

  • Relapse rate: 36-44% 2, 4
  • Maternal mortality: Three deaths occurred in women with persistently low LVEF 2
  • Pregnancy should be strongly advised against 2

Advanced Risk Stratification

Beyond simple LVEF cutoffs, more refined imaging parameters improve risk prediction 6:

• LVEF ≥52% OR Global longitudinal strain ≤-16% on pre-pregnancy echocardiography is associated with low risk of recurrence
• These thresholds are more predictive than the traditional 50% LVEF cutoff

Clinical Implications and Counseling

Absolute Contraindications to Pregnancy

Pregnancy must be strongly discouraged in women with 1, 2:

• LVEF <25% at any time
• Persistent LV dysfunction (LVEF <50%) that has not normalized
• LVEF <20% carries very high maternal mortality and termination should be considered if pregnancy occurs

Counseling for Recovered Patients

Even with normalized LVEF, patients must understand 2:

• One-third will experience recurrence of heart failure symptoms
• LVEF typically decreases during subsequent pregnancy, even if it had recovered
• Risk of death exists, though substantially lower than non-recovered patients
• All patients should be informed that pregnancy can have negative effects on cardiac function and that heart failure and death may occur

Common Pitfalls to Avoid

1. Do not assume normalized LVEF equals no risk: Even with LVEF ≥50%, recurrence occurs in 21-24% of cases 2, 3

2. LVEF alone is insufficient for risk stratification: The 2026 meta-analysis emphasizes that LVEF alone cannot adequately predict outcomes, and individualized assessment with advanced imaging (strain analysis) is essential 3

3. Do not delay counseling: Family planning discussions must occur immediately after index PPCM diagnosis, as these women are typically in their reproductive years 2

Management Framework for Subsequent Pregnancy

If pregnancy occurs despite counseling:

• Mandatory tertiary center monitoring for all patients
• Pre-pregnancy optimization with guideline-directed medical therapy
• Serial echocardiography throughout pregnancy
• Multidisciplinary team (cardiology, maternal-fetal medicine, anesthesia)
• Consider bromocriptine therapy and lactation suppression 1
• Anticoagulation for atrial arrhythmias with LMWH or vitamin K antagonists depending on trimester 1

Contraception Recommendations

Given high recurrence risk, effective contraception is critical 2:

Recommended:

• Intrauterine devices (copper or progestogen-releasing)
• Progestogen-only methods (intramuscular, subcutaneous, subdermal)

Avoid:

• Combined hormonal contraceptives (increased thromboembolism risk)
• Barrier methods (high failure rate)

Consider: Permanent sterilization options after careful counseling, though anesthetic risk must be assessed in those with persistent severe LV dysfunction 2.